Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Broadmark Realty Capital Inc.BRMK · Entity 112778 | Chairman Emeritus | December 31, 2021 | February 10, 2022 |
| Intelligent Medicine Acquisition Corp.IQMD · Entity 11509 | Director | November 04, 2021 | November 04, 2021 |
| OMEROS CORPOMER · Entity 4756 | Director | August 12, 2026 | August 19, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Broadmark Realty Capital Inc.
Report date December 31, 2021 · Filed February 10, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 90,358 |
Reported balance
After 2021-01-08 transaction · row 1
1 source rowRow 1 · 2021-01-08 · Gift · Disposed 50,000 · Balance 90,358 |
| Common StockSEC Table I · non-derivative | IndirectBy Tranceka Capital LLC | 191,706 |
Reported balance
After 2021-02-18 transaction · row 2
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 2 · 2021-02-18 · Gift · Disposed 37,882 · Balance 191,706 F1: Formerly known as Broadmark Capital LLC. F2: Mr. Schocken is the beneficial owner of the shares of common stock of the Issuer held by Tranceka Capital LLC, Tranceka Holdings, LLC, and Tranceka, LLC as he holds voting and dispositive power over such shares. |
| Common StockSEC Table I · non-derivative | IndirectBy Tranceka Holdings, LLC | 1,273,101 |
Reported balance
After 2021-02-18 transaction · row 3
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 3 · 2021-02-18 · Gift · Disposed 251,571 · Balance 1,273,101 F2: Mr. Schocken is the beneficial owner of the shares of common stock of the Issuer held by Tranceka Capital LLC, Tranceka Holdings, LLC, and Tranceka, LLC as he holds voting and dispositive power over such shares. |
| Common StockSEC Table I · non-derivative | IndirectBy Tranceka, LLC | 189,039 |
Reported balance
Holding disclosure · report date 2021-12-31 · row 4
Holding and transaction disclosures are not merged.
1 source rowRow 4 · Balance 189,039 F2: Mr. Schocken is the beneficial owner of the shares of common stock of the Issuer held by Tranceka Capital LLC, Tranceka Holdings, LLC, and Tranceka, LLC as he holds voting and dispositive power over such shares. |
Filing footnotes · ownership attribution and instrument terms
F1: Formerly known as Broadmark Capital LLC.
F2: Mr. Schocken is the beneficial owner of the shares of common stock of the Issuer held by Tranceka Capital LLC, Tranceka Holdings, LLC, and Tranceka, LLC as he holds voting and dispositive power over such shares.
Intelligent Medicine Acquisition Corp.
Report date November 04, 2021 · Filed November 04, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class B Common StockSEC Table II · derivative / convertible security | Direct | Not disclosed |
Reported balance
Holding disclosure · report date 2021-11-04 · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · Balance Not disclosed F1: As described in the issuer's registration statement on Form S-1 (File No. 333-260205) under the heading "Description of Securities--Founder Shares", the shares of Class B common stock will automatically convert into shares of Class A common stock at the time of the issuer's initial business combination on a one-for-one basis (subject to adjustment for stock splits, stock dividends, reorganizations, recapitalizations and the like) and subject to certain anti-dilution rights and have no expiration date. |
Filing footnotes · ownership attribution and instrument terms
F1: As described in the issuer's registration statement on Form S-1 (File No. 333-260205) under the heading "Description of Securities--Founder Shares", the shares of Class B common stock will automatically convert into shares of Class A common stock at the time of the issuer's initial business combination on a one-for-one basis (subject to adjustment for stock splits, stock dividends, reorganizations, recapitalizations and the like) and subject to certain anti-dilution rights and have no expiration date.
OMEROS CORP
Report date August 12, 2026 · Filed August 19, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $13.71 · Expires 2036-08-11 | Direct | 30,000 |
Reported balance
After 2026-08-12 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-08-12 · Grant · Acquired 30,000 · Balance 30,000 F1: This option shall vest and become exercisable in equal annual installments over a three-year period beginning on the first anniversary of the date of grant. |
Filing footnotes · ownership attribution and instrument terms
F1: This option shall vest and become exercisable in equal annual installments over a three-year period beginning on the first anniversary of the date of grant.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 12, 2026 Filed Aug 19, 2026 01:51 UTC | OMEROS CORP OMER · Entity 4756 | GrantStock Option (Right to Buy) · Derivative | 30,000 | $0.00 Strike: $13.71 | $0.00 |
DisclosureSEC source: 0001437749-26-028463 · rdgdoc.xml · derivative · entry 1 Schocken Joseph L · CIK 0001362618 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2036-08-11 F1 · derivative.exercise_date: This option shall vest and become exercisable in equal annual installments over a three-year period beginning on the first anniversary of the date of grant. Read SEC document |
| February 18, 2021 Filed Feb 10, 2022 22:06 UTC | Broadmark Realty Capital Inc. BRMK · Entity 112778 | GiftCommon Stock | 251,571 | $0.00 | $0.00 |
DisclosureSEC source: 0000950138-22-000063 · edgar.xml · nonDerivative · entry 3 Schocken Joseph L · CIK 0001362618 · Chairman Emeritus 10b5-1 filing: Not disclosed Ownership: Indirect · By Tranceka Holdings, LLC Disclosed balance after: 1,273,101 F2 · ownership.nature: Mr. Schocken is the beneficial owner of the shares of common stock of the Issuer held by Tranceka Capital LLC, Tranceka Holdings, LLC, and Tranceka, LLC as he holds voting and dispositive power over such shares. Read SEC document |
| February 18, 2021 Filed Feb 10, 2022 22:06 UTC | Broadmark Realty Capital Inc. BRMK · Entity 112778 | GiftCommon Stock | 37,882 | $0.00 | $0.00 |
DisclosureSEC source: 0000950138-22-000063 · edgar.xml · nonDerivative · entry 2 Schocken Joseph L · CIK 0001362618 · Chairman Emeritus 10b5-1 filing: Not disclosed Ownership: Indirect · By Tranceka Capital LLC Disclosed balance after: 191,706 F1 · ownership.nature: Formerly known as Broadmark Capital LLC. F2 · ownership.nature: Mr. Schocken is the beneficial owner of the shares of common stock of the Issuer held by Tranceka Capital LLC, Tranceka Holdings, LLC, and Tranceka, LLC as he holds voting and dispositive power over such shares. Read SEC document |
| January 08, 2021 Filed Feb 10, 2022 22:06 UTC | Broadmark Realty Capital Inc. BRMK · Entity 112778 | GiftCommon Stock | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000950138-22-000063 · edgar.xml · nonDerivative · entry 1 Schocken Joseph L · CIK 0001362618 · Chairman Emeritus 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,358 Read SEC document |
| February 03, 2020 Filed Feb 5, 2020 22:11 UTC | Broadmark Realty Capital Inc. BRMK · Entity 112778 | GrantCommon Stock | 95,694 | $0.00 | $0.00 |
DisclosureSEC source: 0000950138-20-000064 · edgar.xml · nonDerivative · entry 1 Schocken Joseph L · CIK 0001362618 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,358 F1 · shares: Represents a grant to Mr. Schocken of 95,694 restricted stock units ("RSUs") that vested in full on February 3, 2020. Each RSU represents the right to receive one share of the Issuer's common stock upon vesting. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.